Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Trulieve Cannabis (TRLV) is set to join the Russell 2000 and Russell 3000 indices based on a preliminary membership list. FTSE Russell published the list on November 13, 2026, with final membership scheduled to become effective after market close on December 11, 2026. The planned additions follow Trulieve’s uplisting to the New York Stock Exchange and inclusion in the S&P Total Market, S&P Completion and Morningstar Total Stock Market indices earlier this year.
Positive
- Minor point. Forward-looking: it has not happened yet and may not happen.Planned Russell 2000 and Russell 3000 inclusion adds to Trulieve’s index memberships.
- Minor pointNew York Stock Exchange uplisting and inclusion in three other indices preceded the planned Russell additions.
Negative
- Minor pointRussell index membership remains preliminary; final membership is scheduled to take effect December 11, 2026.
Key Figures
- Russell Indexes assets benchmarked or invested
- Approximately $12 trillion
- U.S. Russell Indexes
- Scheduled effective date
- Dec. 11, 2026
- Final index membership scheduled to become effective after market close
AI-generated analysis. How Rhea-AI works. Not financial advice.
"We are thrilled to join the Russell 2000® and 3000® Indices, following uplisting to the New York Stock Exchange and domestication to
The Russell 2000® Index is a leading benchmark for the small-cap segment of the
Forward-Looking Statements
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from those contained in the forward-looking statements. Risks and uncertainties include, without limitation, the risks and factors discussed under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our periodic reports subsequently filed with the United States Securities and Exchange Commission and in the Company's filings on SEDAR+ at www.sedarplus.ca. There can be no assurance that any forward-looking statements herein will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the NYSE under the symbol TRLV. For more information, please visit Trulieve.com.
Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve
Investor and Media Contact
Christine Hersey, Chief Corporate Affairs and Strategy Officer
+1 (424) 202-0210
Christine.Hersey@Trulieve.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-preliminary-addition-to-the-russell-2000-and-3000-indices-302939750.html
SOURCE Trulieve Cannabis Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When is Trulieve expected to join the Russell 2000 and Russell 3000 indices?
Final index membership is scheduled to become effective after market close on December 11, 2026. Trulieve’s planned addition to both indices is based on FTSE Russell’s preliminary list published November 13, 2026.
Why does Trulieve expect Russell index inclusion to matter?
Trulieve expects index inclusion to raise awareness of the company and lead to greater liquidity and access to institutional investors. These are the company’s expectations, rather than reported outcomes of the planned additions.